Macquarie analyst Tim Nollen maintains Paramount Global (NASDAQ:PARA) with a Neutral and lowers the price target from $16 to $15.
STRATA Skin Sciences Announces The Placement Of Six XTRAC Devices With Dermatology Clinics In Q1 Of 2024 That Are Considered “Comebacks”
STRATA Skin Sciences, Inc. ("STRATA" or the "Company") (NASDAQ:SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions,
